Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes
Open Access
- 24 June 2013
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 11 (1) , 19
Abstract
Background: Small interfering RNA (siRNA) has attracted attention in the field of nucleic acid medicine as a RNA interference (RNAi) application that leads to gene silencing due to specific messenger RNA (mRNA) destruction. However, since siRNA is unstable in blood and unable to cross the cell membrane, encapsulation of siRNA into a carrier is required. Results: In this study, we used a carrier that combined ZHER2-displaying bio-nanocapsule (derived from hepatitis B virus surface antigen) and liposomes in a complex in order to investigate the feasibility of effective and target-cell-specific RNAi applications. As a result, by observing RNAi only in HER2-expressing breast cancer cells, using our proposed methodology, we successfully demonstrated target-cell-specific delivery and effective function expression of siRNA. Conclusions: These findings show that, in the field of nucleic acid medicine, ZHER2-BNC/LP can be a useful carrier for siRNA delivery, and could also become a useful tool for gene silencing and to accomplish protein knock-down.Keywords
This publication has 23 references indexed in Scilit:
- Quantitative Silencing of EGFP Reporter Gene by Self-Assembled siRNA Lipoplexes of LinOS and CholesterolMolecular Pharmaceutics, 2012
- Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapyInternational Journal of Nanomedicine, 2012
- Structural Diversity Repertoire of Gene Silencing Small Interfering RNAsNucleic Acid Therapeutics, 2011
- A Simple and Cost-Effective Method to Transfect Small Interfering RNAs Into Pancreatic Cancer Cell Lines Using PolyethyleniminePancreas, 2011
- Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cellsBioorganic & Medicinal Chemistry Letters, 2010
- PEGylation of biodegradable dextran nanogels for siRNA deliveryEuropean Journal of Pharmaceutical Sciences, 2010
- Lipid-based systemic delivery of siRNAAdvanced Drug Delivery Reviews, 2009
- Specific Protein Delivery to Target Cells by Antibody-displaying BionanocapsulesThe Journal of Biochemistry, 2008
- In Vivo Delivery of Bionanocapsules Displaying Phaseolus vulgaris Agglutinin-L 4 Isolectin to Malignant Tumors Overexpressing N -Acetylglucosaminyltransferase VHuman Gene Therapy, 2008
- Delivery of short interfering RNA using endosomolytic cell‐penetrating peptidesThe FASEB Journal, 2007